Deprecated: Assigning the return value of new by reference is deprecated in D:\Hosting\13026667\html\blog\wp-settings.php on line 399

Deprecated: Assigning the return value of new by reference is deprecated in D:\Hosting\13026667\html\blog\wp-settings.php on line 414

Deprecated: Assigning the return value of new by reference is deprecated in D:\Hosting\13026667\html\blog\wp-settings.php on line 421

Deprecated: Assigning the return value of new by reference is deprecated in D:\Hosting\13026667\html\blog\wp-settings.php on line 456

Deprecated: Assigning the return value of new by reference is deprecated in D:\Hosting\13026667\html\blog\wp-includes\cache.php on line 99

Deprecated: Assigning the return value of new by reference is deprecated in D:\Hosting\13026667\html\blog\wp-includes\query.php on line 21

Deprecated: Assigning the return value of new by reference is deprecated in D:\Hosting\13026667\html\blog\wp-includes\theme.php on line 576
Free Radical Therapy Blog » genetic

Posts Tagged ‘genetic’

Stem Cell Therapy, Cancer and FRT: The Good, the Bad and the Promising (Part Two)

Wednesday, February 16th, 2011

Stem cell harvest

Stem cell harvest

Now for the Promising…

I’m going to start today with a personal twist on stem cell research. More than 10 years ago, the Institute for Health Realities sponsored a super symposium on cancer in Colorado Springs. At the meeting, our featured speaker, Mary Hendricks, Ph.D.*, showed that cancer may use a stem cell to metastasize, becoming most aggressive as it develops its own blood supply (rather than depending upon any existing supply route). Cancer accomplished this feat by mimicking our process of angiogenesis, but with its own unique architecture. With such being the case, it is clear that the new blood supply was no accident. It was all part of cancer’s ongoing strategy.**

Dr. Hendricks then gave us hope of finding an answer to the disease. Cancer, she explained, doesn’t start with a stem cell. It must be acquired later, from us. Cancer begins its life attached to endothelium using a glue-like protein, E-cadherin. It is during this initial stage of attachment that our own body is best equipped to kill it through programmed cell death (apoptosis). If we fail to kill it during its early stage, a time when our body is likely to be suffering the negative impact of the six subclinical defects characteristic of FRT, we run the risk of inadvertently activating a set of enzymes, called the MMPs, that loosen E-cadherin’s grip on the cancer. Upon being set free, the cancer starts to express a set of genetic instructions of its own, some of which work toward recruiting a stem cell from among our own adult stem cells.

The same six subclinical events that allow for the inadvertent activation of MMP enzymes, particularly acid stress and an anaerobic tendency, have long been known to associate with cancer onset. Dr. Otto Warburg won the Nobel Prize for this revelation back in the 1930’s. These imbalances, as was later discovered, impart to the cancer the ability to recruit one of our stem cells for its benefit. It is these key events that give emphasis to the importance of prevention by applying the Designed2Win Model of Health. Stopping cancer early has long been preferred over later, as once it separates from the endothelium the person affected is at greater disadvantage, which then calls for medical intervention.

In the coming weeks and months much discussion will appear in the news relative to how science is planning to counter the possibility of transplanting cancer during stem cell therapy. Someone will find a way to lessen the risk. Yet, the key point to take away from this, is that clinicians should get very serious with their patients with the concept of prevention. Free Radical Therapy may be the best approach to this end, as it deals with the six subclinical events important for maintaining the integrity of E-cadherin long enough for our immune system to kill the cancer early on. Similarly, there is some evidence that addressing the six cellular subclinical homeostatic controls assessed through chemistry may likewise protect T cell function while helping to derail cancer’s ability to recruit our adult stem cell for its own benefit.

“Prevention has its own rewards, that you may never know the disease you are trying to prevent.” ~ Author unknown


* Dr. Mary Hendricks was president of FASEB at the time of the seminar. FASEB is the largest life science organization in the world, with 70,000 member scientists. Her discovery that cancer undergoes angiogenesis mimicry provided an important answer to why anti-angiogenesis drugs often fail, and what you might do to correct the problem.

** The complete recording from this symposium is available from our office. Ask for the Super Symposium 2000 series, or order here.